This review outlines the structural and functional aspects as well as the key knowledge gap of IL-1-producing ASC-inflammasomes—specifically the convergence of ASC-inflammasome pathways and serum amyloid A (SAA)—and gut microbiota in the pathogenesis of PSC and IBD. Here, SAA2 is linked to inflammatory bowel disease.